Connect with us

News

England appoints Women’s Health Ambassador to tackle gender health gap

The Women’s Health Ambassador will support the implementation of the upcoming women’s health strategy

Published

on

Women’s health and care will be improved following the appointment of Dame Lesley Regan as the government’s first ever Women’s Health Ambassador for England.

The strategy aims to tackle the gender health gap and ensure services meet the needs of women throughout their life. Bringing with her a raft of expertise spanning a 42-year career in women’s health, Dame Lesley Regan will support the implementation of the upcoming women’s health strategy.

She will continue in her role as Professor of Obstetrics and Gynaecology at Imperial College London St Mary’s Hospital Campus, and remains in active clinical practice.

“Having spent my career working with and caring for women, it is a great honour to be appointed as Women’s Health Ambassador for the first government-led women’s health strategy in England,” she said.

“This is an important opportunity to get it right for women and girls, and make a real difference to 51 per cent of our population by addressing the inequalities that exist across society. I look forward to working with women, girls, health services, charities, policy makers, the government and other key partners to implement this strategy.”

Health and Social Care Secretary, Sajid Javid, said: “The healthcare system needs to work for everyone, and I am committed to tacking inequalities which exist within it, particularly for women.

“Closing the gender health gap is critical for a fair health and care system in the future. I look forward to working closely with Dame Lesley on our shared mission to ensure all women feel listened to by the health and care system and are able to access the support and services they need.”

Closing the gender health gap is vital to the government’s wider levelling up ambition. A lack of support, awareness and understanding of health conditions specific to women can be harmful not only to the health and happiness of women, but the health of the economy.

One in four women consider leaving their job as a result of the menopause, and ensuring women have the right support in place to stay in the workplace for longer will not only enable them to live fulfilled lives, but help to boost the economy and help tackle the rising costs of living.

The Civil Service recently signed the Wellbeing of Women Menopause Workplace Pledge, committing to ensuring those going through the menopause are supported.

Dame Lesley will be instrumental in driving forward the system-level changes needed to close the gender health gap and eradicating deep seated biases.

“Since we launched our Women’s Health call for evidence over a year ago, we have made great progress in raising the profile of women’s health,” said Maria Caulfield, Minister for Women’s Health. “From the formation of the UK-wide menopause taskforce and publication of our vision document, to legislating to ban hymenoplasty and virginity testing and appointing a chair of the HRT taskforce to help more menopausal women access this lifeline medication.

“The appointment of Dame Lesley as the Women’s Health Ambassador for England is yet another step in the right direction to giving women’s health the platform and profile it needs.”

She added that: “We are embarking on an important journey to eradicate the gender health gap. There is no quick fix. But I look forward to working together with Dame Lesley as we take the next steps to implement our women’s health strategy and beyond.”

The appointment of Dame Lesley will be followed by the appointment of a deputy ambassador who will work closely with her and be responsible for increasing awareness of the women’s health strategy and its ambitions, better understanding the barriers and issues of concern of under-served groups of women and girls.

This is the latest step taken by the government to ensure women’s healthcare needs are met. This includes taking action to increase access and reduce the cost of HRT meaning women can pay a one-off charge equivalent to two single prescription charges, currently £18.70, for all their HRT prescriptions for a year.

The government hopes that the creation of a prepayment certificate will mean women can access HRT on a month-by-month basis if need be, easing pressure on supply, while keeping the cost of HRT low. The system will be implemented by April 2023.

 

News

Research project of the year shortlist revealed

Published

on

The Femtech World Awards is proud to reveal the shortlist for Research Project of the Year as part of the third annual global celebration of innovation, impact and leadership across women’s health.

From fertility science and perimenopause research to regional ecosystem analysis, the shortlisted projects reflect the breadth and growing influence of femtech research worldwide.

The category is sponsored by OncoGenomX, with the winner to be selected by a representative from the organisation.

OncoGenomX is dedicated to offering solutions and providing comprehensive support services that empower Drug Developers, Clinical Researchers, Oncologists,NextGenSeq Diagnostics Laboratories, NextGenSeq Service Organisations, Cancer Diagnostics and Therapeutics Companies to achieve their ambitious goals

The shortlisted entries for Research Project of the Year are:

Women’s health remains significantly underserved in South-East Asia, with persistent gaps in access, awareness, and quality of care carrying substantial social and economic costs.

This report examines the femtech landscape in Indonesia, the Philippines, Singapore, Thailand, and Vietnam, highlighting market trends, emerging technologies including artificial intelligence, and the evolving support ecosystem.

It identifies key challenges facing femtech founders, including limited access to finance, low awareness and persistent stigma, marketing constraints linked to content moderation, and gaps in tailored ecosystem support.

 

Led by Stephanie Willson, MD, of the IVI RMA Global Research Alliance, the study explored whether embryos that show certain chromosome abnormalities during genetic testing may still have the potential to result in a healthy pregnancy and live birth.

The research analysed more than 7,600 frozen embryo transfers and found that some embryos previously considered unlikely to succeed were still capable of leading to successful pregnancies, although at lower rates than embryos without abnormalities.

The findings could help fertility clinics and patients make more informed decisions during IVF treatment, particularly in cases where there are limited embryos available.

Rather than automatically discarding these embryos, the research supports a more evidence-based and personalised approach to fertility care.

For many women, perimenopause can feel confusing and unpredictable, with limited research explaining what is happening in their bodies.

Natural Cycles set out to change that by leading one of the largest studies ever conducted on menstrual and ovulatory patterns, uncovering new insights into how ovulation behaves as women approach menopause.

Conducted in collaboration with researchers from George Washington University, Seattle Clinical Research Center, Gennev and the University of California San Diego, the study analysed nearly one million menstrual cycles from more than 197,000 women aged 18–52 across more than 140 countries.

The scale of this dataset made it possible to explore menstrual patterns and ovulation in far greater detail than has traditionally been possible in women’s health research.

The Femtech World Awards celebrates the innovators, researchers and organisations driving meaningful progress in women’s health.

What happens next

Winners across all categories will be revealed during the virtual ceremony on June 19, with winners receiving a trophy and an interview with a Femtech World journalist.

Continue Reading

Mental health

Women over 40 seeking raves for mental health benefits

Published

on

Women over 40 are seeking raves for mental and physical wellbeing, with a study suggesting the benefits go beyond nightlife.

The findings challenge the idea that nightlife and electronic dance music events are mainly for younger people.

Published in Psychology of Music, the study focused on the common misconception that nightlife is only for younger audiences.

Researchers surveyed 136 female clubbers aged 40 to 65 about their experiences at electronic dance music events.

The study, carried out at the University of Leeds in England, found women reported mental and physical wellbeing benefits from attending these events.

Seeing favourite DJs was the most common motivation, but many women also described dancing as a way to relieve stress and find emotional support.

The research found that 65.9 per cent of participants described attending a rave as “spiritual”, while 62.9 per cent said it offered an escape from everyday life.

A further 58.3 per cent said they felt like a different version of themselves in a club environment.

Nine in ten participants said they felt at home at electronic dance music events, with many pointing to a shared passion for music and the sense of community around it.

The study also suggested physical fitness played a role, with some women saying they had made clubbing part of their regular exercise routine.

However, the findings also highlighted challenges for older women in nightlife spaces.

One fifth of participants said they felt visibly out of place because of their age.

Nearly half reported unwanted physical contact, leading some to seek out different venues or attend only with friends.

Continue Reading

News

Osteoporosis significantly increases risk of death in menopause, study suggests

Published

on

Osteoporosis may raise the risk of death in postmenopausal women by up to 47 per cent, a new study suggests.

The findings point to an inverse relationship between femoral bone mineral density and mortality risk, especially within certain ranges.

Femoral bone mineral density is the amount of mineral in the thigh bone, which is often measured to assess bone strength and osteoporosis risk.

Dr Monica Christmas is associate medical director for The Menopause Society.

She said: “Osteoporosis often remains a silent threat after menopause, despite its profound effect on women’s lives—from loss of height, poor balance, and reduced mobility to disfigurement, pain, and even premature death.

“Early screening and preventive measures, including a calcium-rich diet (preferably from food sources), regular weight-bearing exercise, and hormone therapy when appropriate, can significantly improve bone health and reduce risks not only of fractures but also cardiovascular disease, certain cancers, and dementia.

“It’s time we bring this conversation to the forefront.”

In the  study involving nearly 3,000 postmenopausal women, bone mineral density at four femoral sites was assessed using dual-energy x-ray absorptiometry, a scan commonly used to measure bone strength and fracture risk.

The analysis found that mortality risk was significantly higher when femoral bone mineral density reached the osteoporotic threshold or when osteoporotic fractures were present.

After full adjustment, osteoporosis was associated with a 47 per cent increased risk of mortality.

A stronger inverse association between increased bone mineral density and mortality risk was seen within specific ranges, suggesting bone mineral density could serve as a prognostic marker of wider health.

The relationship appeared especially notable within the range of 0.46 to 0.71 g/cm² for total femur bone mineral density.

Previous research has shown that postmenopausal women face a significantly higher risk of death within one year of hip or vertebral fractures.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.